Several microRNAs were implicated in the aggressive phenotype seen in EOBC; eight microRNAs were differentially expressed in estrogen receptor-positive breast tumors from young age patients (35 years or less) compared to tumors from older patients (50–65 years). The gene discussed is ESR1; the disease is breast neoplasm.